KRAS and neoplasm: The decreased M2-polarized macrophages and intratumoral immunosuppressive myeloid-derived suppressor cells (MDSC) in KRAS (G12C) tumors, via modulating the tumor’s RNA expressions and protein, are involved in tumor antigen presentation or immunosuppressive TME mediation [151].